foxo4-dri senolytic peptide mechanism UK | Research Frontiers | FOXO4-DRI regulates endothelial
Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine
Pay in 4 interest-free payments of $6.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



